MyFinsight
Home
About
Contact
Back
Income Statement
Aurinia Pharmaceuticals Inc. (AUPH)
source: myfinsight.com
Download
Download image
License Collaboration
And Royalty Revenue
$3,434K
Product
$66,574K
Total revenue
$70,008K
(22.41%↑ Y/Y)
Interest income
$3,190K
Income (loss) from
operations
$20,083K
(1427.36%↑ Y/Y)
Total operating
expenses
$49,925K
(-14.96%↓ Y/Y)
Net income (loss)
before income taxes
$22,156K
(1399.05%↑ Y/Y)
Interest expense
$1,117K
Cost of revenue
$7,115K
(-20.14%↓ Y/Y)
Selling, general and
administrative
$26,018K
(-42.10%↓ Y/Y)
Other expense
(income), net
-$9,246K
(-3288.28%↓ Y/Y)
Research and development
$7,432K
(82.16%↑ Y/Y)
Restructuring
$114K
(-89.37%↓ Y/Y)
Net income (loss)
$21,513K
(2879.64%↑ Y/Y)
Income tax expense
$643K
(-14.95%↓ Y/Y)
Comprehensive income (loss)
$21,433K
(2889.26%↑ Y/Y)
Unrealized loss on
available-for-sale securities
-$80K
(-1500.00%↓ Y/Y)
Back